Yu, Daqi
Ren, Yandong https://orcid.org/0000-0003-1595-8994
Uesaka, Masahiro
Beavan, Alan J. S.
Muffato, Matthieu
Shen, Jieyu https://orcid.org/0000-0002-5450-6985
Li, Yongxin https://orcid.org/0000-0002-9555-1387
Sato, Iori https://orcid.org/0000-0001-7077-6646
Wan, Wenting
Clark, James W. https://orcid.org/0000-0003-2896-1631
Keating, Joseph N. https://orcid.org/0000-0002-2667-7795
Carlisle, Emily M.
Dearden, Richard P. https://orcid.org/0000-0003-3522-7304
Giles, Sam https://orcid.org/0000-0001-9267-4392
Randle, Emma https://orcid.org/0000-0002-6571-5491
Sansom, Robert S. https://orcid.org/0000-0003-1926-2556
Feuda, Roberto https://orcid.org/0000-0003-0857-1732
Fleming, James F.
Sugahara, Fumiaki
Cummins, Carla
Patricio, Mateus
Akanni, Wasiu
D’Aniello, Salvatore
Bertolucci, Cristiano https://orcid.org/0000-0003-0252-3107
Irie, Naoki https://orcid.org/0000-0002-6720-381X
Alev, Cantas https://orcid.org/0000-0002-4879-8782
Sheng, Guojun https://orcid.org/0000-0001-6759-3785
de Mendoza, Alex https://orcid.org/0000-0002-6441-6529
Maeso, Ignacio https://orcid.org/0000-0002-6440-8457
Irimia, Manuel https://orcid.org/0000-0002-2179-2567
Fromm, Bastian https://orcid.org/0000-0003-0352-3037
Peterson, Kevin J.
Das, Sabyasachi https://orcid.org/0000-0002-9116-9623
Hirano, Masayuki https://orcid.org/0000-0002-2455-9189
Rast, Jonathan P.
Cooper, Max D. https://orcid.org/0000-0003-0887-8785
Paps, Jordi https://orcid.org/0000-0003-2636-6636
Pisani, Davide https://orcid.org/0000-0003-0949-6682
Kuratani, Shigeru
Martin, Fergal J. https://orcid.org/0000-0002-1672-050X
Wang, Wen
Donoghue, Philip C. J. https://orcid.org/0000-0003-3116-7463
Zhang, Yong E. https://orcid.org/0000-0003-3770-2383
Pascual-Anaya, Juan https://orcid.org/0000-0003-3429-9453
Article History
Received: 6 April 2023
Accepted: 4 December 2023
First Online: 12 January 2024
Competing interests
: M.D.C. is a cofounder and shareholder of NovAb, Inc., which produces lamprey antibodies for biomedical purposes. J.P.R. is a consultant for NovAb. The other authors declare no competing interests.